| View |
|
DR-XY40305
|
Famotidine + Calcium Carbonate + Magnesium Hydroxide
|
Fulzimed
|
10mg/800mg/ 165mg
|
Chewable Tablet
|
H-2 Receptor antagonist / Antacid
|
Lloyd Laboratories, Inc.
|
Philippines
|
Automatic Renewal
|
09 October 2021
|
17 November 2026
|
| View |
|
DR-XY40309
|
Sildenafil (as Citrate)
|
Greatafil Max
|
100mg
|
Film-Coated Tablet
|
Phosphodiesterase-5 Inhibitor
|
Flamingo Pharmaceuticals Ltd.
|
India
|
Automatic Renewal
|
03 August 2021
|
17 November 2026
|
| View |
|
DR-XY40311
|
Sodium Chloride
|
None
|
0.009
|
Solution for Infusion
|
Parenteral Electrolyte Solution
|
Marion Laboratories (Pvt.) Ltd.
|
Pakistan
|
Automatic Renewal
|
26 November 2021
|
17 November 2026
|
| View |
|
DR-XY40316
|
Levodopa + Benserazide (As Hydrochloride)
|
Madopar HBS
|
100 mg/ 25 mg
|
Tablet
|
Antiparkinsonism (Dopaminergic)
|
Delpharm Milano S.r.L
|
italy
|
Initial (Variation)
|
25 August 2022
|
25 August 2027
|
| View |
|
DR-XY40317
|
5% Dextrose In 0.9% Sodium Chloride
|
None
|
Formulation Each 100 mL contains: Dextrose Monohydrate- 5 g Sodium Chloride- 900 mg
|
Solution For Intravenous Infusion
|
Electrolyte Replenisher
|
Sichuan Kelun Pharmaceutical Co. Ltd.
|
China
|
Automatic Renewal
|
23 March 2021
|
22 November 2026
|
| View |
|
DR-XY40319
|
Hyoscine butylbromide
|
Gascosin
|
20 mg/mL
|
Solution for injection (IV/IM/SC)
|
Anticholinergic
|
Zhejiang Ruixin Pharmaceutical Co., Ltd.
|
China
|
Automatic Renewal
|
21 September 2021
|
21 November 2026
|
| View |
|
DR-XY40321
|
Xylometazoline Hydrochloride
|
Xylonas
|
1mg/ mL (0.1%)
|
Nasal Solution (Drops)
|
Nasal Decongestant
|
Geofman Pharmaceuticals
|
Pakistan
|
Automatic Renewal
|
20 October 2021
|
21 November 2026
|
| View |
|
DR-XY40331
|
Clarithromycin
|
Klaryz
|
500mg
|
Film-Coated Tablet
|
Antibacterial
|
Drugmaker's Laboratories, Inc.
|
Philippines
|
Automatic Renewal
|
06 December 2021
|
22 November 2026
|
| View |
|
DR-XY40334
|
Gemcitabine
|
Citagem
|
200 mg
|
Lyophilized Powder For I.V Infusion
|
-
|
Beacon Pharmaceuticals Limited
|
Bangladesh
|
-
|
15 June 2021
|
23 November 2026
|
| View |
|
DR-XY40335
|
Gemcitabine
|
Citagem
|
1 g
|
Lyophilized Powder For I.V Infusion
|
-
|
Beacon Pharmaceuticals Limited
|
Bangladesh
|
-
|
15 June 2021
|
23 November 2026
|
| View |
|
DR-XY40337
|
Tacrolimus
|
Tacros Forte
|
1mg/g (0.1%w/w)
|
Ointment
|
Immunosuppressant
|
Glenmark Pharmaceuticals Limited
|
India
|
Automatic Renewal
|
04 February 2022
|
23 November 2026
|
| View |
|
DR-XY40348
|
Clarithromycin
|
Unbranded
|
125mg/5mL
|
Granules For Suspension
|
Antibacterials
|
Pascual Laboratories Inc
|
Philippines
|
Renewal
|
03 December 2023
|
01 December 2028
|
| View |
|
DR-XY40351
|
Ciprofloxacin (as Lactate)
|
Megaflox
|
2mg/ mL (200mg/ 100mL)
|
Solution for I.V. Infusion
|
Antibacterial (Fluoroquinolone)
|
Geofman Pharmaceuticals
|
Pakistan
|
Automatic Renewal
|
07 December 2021
|
28 November 2026
|
| View |
|
DR-XY40354
|
Amino Acids Crystalline
|
AMINOPLASMAL B. BRAUN 5% E
|
0.05
|
Solution for Infusion (I.V.)
|
Parenteral Nutrition
|
B. BRAUN MELSUNGEN AG
|
Germany
|
Automatic Renewal
|
09 August 2021
|
15 December 2026
|
| View |
|
DR-XY40361
|
Oxaliplatin
|
Oxalee
|
50 mg
|
Lyophilized Powder For IV Infusion
|
-
|
Laboratorios Richmond S.A.C.I.F.
|
Argentine
|
-
|
15 June 2021
|
29 November 2026
|
| View |
|
DR-XY40362
|
Oxaliplatin
|
Oxalee
|
100 mg
|
Lyophilized Powder For I.V Infusion
|
-
|
Laboratorios Richmond S.A.C.I.F.
|
Argentine
|
-
|
15 June 2021
|
29 November 2026
|
| View |
|
DR-XY40363
|
Ephedrine (As Hydrochloride)
|
Drinex
|
40mg/mL
|
Solution For injection (Im/Iv)
|
Sympathomimetic
|
Taiwan Biotech Co., Ltd.
|
Taiwan
|
Renewal
|
21 April 2022
|
17 May 2027
|
| View |
|
DR-XY40369
|
Carvedilol
|
Carvida 6.25
|
6.25 mg
|
Tablet
|
Alpha and Beta-Receptor Blocking Agents
|
Delta Pharma Limited
|
Bangladesh
|
Renewal
|
10 October 2024
|
06 December 2029
|
| View |
|
DR-XY40378
|
Trimetazidine dihydrochloride
|
Trivasc
|
35 mg
|
Monitored-Release Tablet
|
Anti-Angina
|
Lloyd Laboratories,Inc.
|
Philippines
|
Automatic Renewal
|
21 January 2022
|
07 December 2026
|
| View |
|
DR-XY40380
|
Dexamethasone Phosphate (as Sodium)
|
Cortix
|
5mg/ mL
|
Solution for Injection
|
Corticosteroid
|
Kwality Pharmaceuticals Pvt. Ltd.
|
India
|
Automatic Renewal
|
19 October 2021
|
07 December 2026
|